Regulation of arsenic methylation: identification of the transcriptional region of the human AS3MT gene.

Cell Biol Toxicol

Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL, 33199, USA.

Published: October 2022

The human enzyme As(III) S-adenosylmethionine methyltransferase (AS3MT) catalyzes arsenic biotransformations and is considered to contribute to arsenic-related diseases. AS3MT is expressed in various tissues and cell types including liver, brain, adrenal gland, and peripheral blood mononuclear cells but not in human keratinocytes, urothelial, or brain microvascular endothelial cells. This indicates that AS3MT expression is regulated in a tissue/cell type-specific manner, but the mechanism of transcriptional regulation of expression of the AS3MT gene is not known. In this study, we define the DNA sequence of the core promoter region of the human AS3MT gene. We identify a GC box in the promoter to which the stress-related transcription factor Sp1 binds, indicating involvement of regulatory elements in AS3MT gene expression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571124PMC
http://dx.doi.org/10.1007/s10565-021-09611-2DOI Listing

Publication Analysis

Top Keywords

as3mt gene
16
region human
8
human as3mt
8
as3mt
7
regulation arsenic
4
arsenic methylation
4
methylation identification
4
identification transcriptional
4
transcriptional region
4
human
4

Similar Publications

AS3MT, GSTO2, and GSTP1 genes play important roles in the arsenic biotransformation pathway, while CYP2E1 gene has a prominent role in the metabolic activation of xenobiotics. Hence, polymorphisms of these genes might have an effect on arsenic biotransformation and could impact susceptibility to arsenical skin lesions in individuals of chronic arsenic toxicity. The present case-control study, comprising 148 subjects, attempted to evaluate genetic association between nine polymorphisms of AS3MT, GSTO2, GSTP1 and CYP2E1 genes and arsenical skin lesions in a West Bengal (WB) population.

View Article and Find Full Text PDF

Disentangling the genetic overlap between ischemic stroke and obesity.

Diabetol Metab Syndr

December 2024

Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, People's Republic of China.

Objective: Obesity has been recognized as a risk factor for cerebrovascular diseases, with observational studies suggesting a heightened incidence of stroke. However, the genetic epidemiology field has yet to reach a consensus on the causal relationship and genetic overlap between ischemic stroke (IS) and obesity.

Methods: We utilized linkage disequilibrium score regression, high-definition likelihood, and local analysis of variant associations to assess the genetic correlation between body mass index (BMI) and IS.

View Article and Find Full Text PDF

Metabolism of inorganic arsenic in mice carrying the human AS3MT gene and fed folate deficient or folate supplemented diet.

Toxicol Appl Pharmacol

November 2024

Department of Nutrition, CB# 7461, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7461, USA. Electronic address:

Arsenic (+3 oxidation state) methyltransferase (AS3MT) catalyzes the S-adenosylmethionine (SAM)-dependent methylation of inorganic arsenic (iAs), yielding monomethyl‑arsenic (MAs) and dimethyl‑arsenic (DMAs) metabolites. The formation of DMAs in this pathway is considered a key mechanism for iAs detoxification. Availability of SAM for iAs methylation depends in part on dietary intake of folate.

View Article and Find Full Text PDF

Genetic Influence of the Brain on Muscle Structure: A Mendelian Randomization Study of Sarcopenia.

J Cachexia Sarcopenia Muscle

February 2025

Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Article Synopsis
  • - The study investigates the relationship between brain structure and function and sarcopenia-related traits, aiming to clarify how brain factors may influence muscle loss and strength in older adults.
  • - Data from the UK Biobank and GTEx Consortium involved over 8,400 participants, using advanced statistical methods to analyze genetic and imaging data for their impact on muscle metrics like lean mass and grip strength.
  • - Findings revealed numerous brain imaging phenotypes that causally impact lean mass and strength, highlighting the complex interplay between neurological health and muscle deterioration.
View Article and Find Full Text PDF

Maternal arsenic exposure modifies associations between arsenic, folate and arsenic metabolism gene variants, and spina bifida risk: A case‒control study in Bangladesh.

Environ Res

November 2024

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Neurology, Boston Children's Hospital, Boston, MA, USA. Electronic address:

Article Synopsis
  • Spina bifida is a neural tube defect linked to genetic and environmental factors, specifically maternal arsenic exposure, which affects fetal development during pregnancy.
  • The study analyzed data from 262 mothers and 220 infants in Bangladesh to explore the relationship between maternal arsenic levels and spina bifida risk, focusing on specific genetic variations in folate and arsenic metabolism.
  • Results indicated that certain single-nucleotide polymorphisms (SNPs) related to arsenic metabolism in infants and mothers significantly increased the likelihood of spina bifida when combined with high arsenic exposure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!